Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. 8951-CL-5201

   Astellas Pharma GmbH

   First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma.

   phase 2 · small molecule · active

   1 trial →

2. 89Zr-Girentuximab

   Telix Innovations

   Clear Cell Renal Cell Carcinoma (ccRCC)

   phase 2 · small molecule · active

   1 trial →

3. 89Zr-girentuximab for PET/CT imaging of CAIX positive tumors

   Telix Innovations

   Cervical Cancer

   phase 2 · other · terminated

   1 trial →

4. 9-ING-41

   ACTUATE THERAPEUTICS, INC.

   Pancreatic Adenocarcinoma

   phase 2 · small molecule · terminated

   1 trial →

5. 9-ING-41

   ACTUATE THERAPEUTICS, INC.

   Salivary Gland Cancer

   phase 2 · small molecule · active

   1 trial →

6. 9-ING-41

   ACTUATE THERAPEUTICS, INC.

   Cancer

   phase 2 · small molecule · active

   1 trial →

7. 9-ING-41

   ACTUATE THERAPEUTICS, INC.

   Salivary Gland Carcinoma

   phase 2 · small molecule · terminated

   1 trial →

8. 9785-CL-0123

   Astellas Pharma GmbH

   Prostate Cancer

   phase 2 · small molecule · active

   1 trial →

9. A Clinical Trial for Patients with Advanced Cancers

   Corbus Pharmaceuticals Holdings

   Advanced Solid tumour

   phase 2 · other · active

   1 trial →

10. A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)

    Merck Sharp and Dohme

    Cancer – Solid Tumors : 1L NSCLC and all other advanced or metastatic solid tumors with KRAS alterations (KRAS mutation or KRAS amplification)

    phase 2 · other · active

    1 trial →

11. A study of niraparib in combination with abem... for Ovarian cancer

    Fondazione Telethon ETS

    Ovarian cancer

    phase 2 · other · active

    1 trial →

12. A5481092

    Pfizer Australia Pty Ltd

    recurrent/refractory Ewing sarcoma, recurrent or refractory neuroblastoma

    phase 2 · small molecule · active

    1 trial →

13. AB-101

    Artiva Biotherapeutics

    Non Hodgkin Lymphoma

    phase 2 · small molecule · completed

    1 trial →

14. AB-201

    Artiva Biotherapeutics

    Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

15. AB18001

    AB Science

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

16. AB680

    Arcus Biosciences

    Metastatic Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

17. ABC2

    Sana Biotechnology

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

18. ABC294640

    Apogee Therapeutics

    Carcinoma, Hepatocellular

    phase 2 · small molecule · terminated

    1 trial →

19. ABC294640

    RedHill Biopharma

    Cholangiocarcinoma

    phase 2 · small molecule · completed

    1 trial →

20. ABC294640

    Apogee Therapeutics

    Diffuse Large B Cell Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

21. ABCSG 45

    Shanghai Reinovax Biologics Co.,LTD

    Early invasive triple negative breast cancer with positive HRD status (acc. to Myriad mychoice© test)

    phase 2 · small molecule · active

    1 trial →

22. ABCSG 63

    Shanghai Reinovax Biologics Co.,LTD

    endocrine-responsive HER2-negative early breast cancer

    phase 2 · small molecule · active

    1 trial →

23. ABEMACICLIB , RO7197597

    Fondazione Telethon ETS

    ER-positive, HER2-negative Early breast cancer

    phase 2 · small molecule · active

    1 trial →

24. ABT-C11-2020

    Lacuna Pharma Pty Ltd

    Metastatic pancreatic ductal adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

25. ACE-CL-001

    Lacuna Pharma Pty Ltd

    Richter's Syndrome, Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia

    phase 2 · small molecule · active

    1 trial →

26. ACE-LY-003

    Lacuna Pharma Pty Ltd

    Relapsed/Refractory marginal zone lymphoma

    phase 2 · small molecule · active

    1 trial →

27. ACE-LY-004

    Lacuna Pharma Pty Ltd

    Mantle Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

28. ACR-368

    Acrivon Therapeutics

    Endometrial Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

29. ACR-368-201

    Acrivon Therapeutics

    Endometrial cancer

    phase 2 · small molecule · active

    1 trial →

30. ACT16146

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 · small molecule · active

    1 trial →

31. ACT16482-01

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 · small molecule · active

    1 trial →

32. ACT16482-03

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 · small molecule · active

    1 trial →

33. ACT16482-04

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 · small molecule · active

    1 trial →

34. ACT16482-05

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 · small molecule · active

    1 trial →

35. ACT16482-06

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 · small molecule · active

    1 trial →

36. ACT17453

    Sanofi-aventis Healthcare Pty Ltd

    Cancer - Relapsed/refractory multiple myeloma

    phase 2 · small molecule · active

    1 trial →

37. ACTIQ®

    Teva Pharma GmbH

    Cancer

    phase 2 · small molecule · completed

    1 trial →

38. ADCETRIS 50 mg powder for concentrate for solution for infusion

    Takeda

    Hodgkin lymphoma (HL) - Hodgkin lymphoma (HL), a neoplasm of lymphoid tissue which is histopathologically defined by the presence of malignant Hodgkin Reed-Sternberg (HRS) cells in a background of inflammatory cells. The proposed pediatric study has been designed to evaluate brentuximab vedotin as a component of a multiagent frontline chemotherapy regimen in patients with advanced stage, newly diagnosed HL, here defined as Stage III and Stage IV and a ≥50 Lansky Play-Performance or Karnofsky Performance Status.

    phase 2 · small molecule · active

    1 trial →

39. ADCT-301

    ADC Therapeutics SA

    Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · terminated

    1 trial →

40. ADENOVIRUS/PSA VACCINE

    United Therapeutics Europe Ltd

    Hormone Refractory Prostate Cancer

    phase 2 · mab · completed

    1 trial →

41. ADJUBIL

    The George Institute

    Biliary tract cancer

    phase 2 · small molecule · active

    1 trial →

42. ADSTILADRIN

    Ferring Pharmaceuticals

    Low-grade upper track urothelial carcinoma (LG-UTUC)

    phase 2 · small molecule · active

    1 trial →

43. AFM13

    Artiva Biotherapeutics

    Relapsed or Refractory Hodgkin Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

44. AG-013736

    Pfizer

    Thyroid Neoplasms

    phase 2 · small molecule · completed

    1 trial →

45. AG-120

    Agios Netherlands B.V.

    Chondrosarcoma

    phase 2 · small molecule · active

    1 trial →

46. AG-221-AML-005

    Celgene Europe Limited

    Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · active

    1 trial →

47. AK104

    Akeso

    Advanced Malignant Tumors

    phase 2 · small molecule · active

    1 trial →

48. AK104

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Resectable Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions